Medication info
K-Pill 5 mg (Tadalafil)

K-Pill 5 mg (Tadalafil)

Prescription medicationTabletOral
Ingredient · strength
Tadalafil›5mg / 1 tablet
Manufacturer / importer
KS Pharma Co., Ltd.
Appearance
Yellow film-coated tablets with a rounded triangular shape
Packaging
30 tablets/box [(10 tablets/PTP)*3]
Approval status
Active

MFDS item code 202106107 · Approved 2021.08.23

Summary

Main use
Treatment of symptoms of erectile dysfunction, benign prostatic hyperplasia, or both conditions
Who takes it
Adults · Children
Adult dose
Do not crush this medicine. Take one tablet whole. For oral administration. 1. Erectile dysfunction Use in adult men For patients who are expected to use tadalafil frequently (at least twice a week), the recommended dose is up to 5mg once daily, taken at approximately the same time each day. The appropriateness of continuous daily dosing should be reassessed periodically. 2. Once-daily treatment for benign prostatic hyperplasia The recommended dose of this medicine for once-daily use is 5mg, taken at approximately the same time each day. 3. Once-daily treatment for erectile dysfunction and benign prostatic hyperplasia The recommended dose of this medicine for once-daily use is 5mg, taken at approximately the same time each day, regardless of the timing of sexual activity. 4. Special populations ● Use in older men No dosage adjustment is required in older patients. ● Use in men with renal impairment - Erectile dysfunction No dose adjustment is required in patients with mild to moderate renal impairment. Once-daily tadalafil is not recommended in patients with severe renal impairment. [See Precautions for Use, 3.2) and section 11.2) Pharmacokinetic properties]. - Benign prostatic hyperplasia No dose adjustment is required in patients with mild renal impairment. Once-daily tadalafil is not recommended in patients with severe renal impairment. [See Precautions for Use, 3.3) and section 11.2) Pharmacokinetic properties]. ● Use in men with hepatic impairment Once-daily dosing has not been evaluated in patients with hepatic impairment. Therefore, if prescribing, the physician should carefully assess the individual benefit/risk. (See section 11. <Special populations>.) ● Use in men with diabetes No dose adjustment is required in patients with diabetes.
Child dose
● Use in children and adolescents Persons under 18 years of age: This medicine should not be used.

Ingredients

Manufacturer
KS Pharma Co., Ltd.

Efficacy & effects

Treatment of symptoms of erectile dysfunction, benign prostatic hyperplasia, or both conditions

  • Erectile dysfunction
  • benign prostatic hyperplasia
  • signs and symptoms of erectile dysfunction and benign prostatic hyperplasia.
View approved original text

This medication is primarily used to treat erectile dysfunction in men and requires sexual stimulation for effectiveness. It is also not used in women. Additionally, it is utilized for the treatment of symptoms associated with benign prostatic hyperplasia. Particularly, it helps men who experience both erectile dysfunction and benign prostatic hyperplasia to improve both issues simultaneously. This drug is effective in improving male sexual function and prostate health.

How to take

Adult dose

Do not crush this medicine. Take one tablet whole. For oral administration. 1. Erectile dysfunction Use in adult men For patients who are expected to use tadalafil frequently (at least twice a week), the recommended dose is up to 5mg once daily, taken at approximately the same time each day. The appropriateness of continuous daily dosing should be reassessed periodically. 2. Once-daily treatment for benign prostatic hyperplasia The recommended dose of this medicine for once-daily use is 5mg, taken at approximately the same time each day. 3. Once-daily treatment for erectile dysfunction and benign prostatic hyperplasia The recommended dose of this medicine for once-daily use is 5mg, taken at approximately the same time each day, regardless of the timing of sexual activity. 4. Special populations ● Use in older men No dosage adjustment is required in older patients. ● Use in men with renal impairment - Erectile dysfunction No dose adjustment is required in patients with mild to moderate renal impairment. Once-daily tadalafil is not recommended in patients with severe renal impairment. [See Precautions for Use, 3.2) and section 11.2) Pharmacokinetic properties]. - Benign prostatic hyperplasia No dose adjustment is required in patients with mild renal impairment. Once-daily tadalafil is not recommended in patients with severe renal impairment. [See Precautions for Use, 3.3) and section 11.2) Pharmacokinetic properties]. ● Use in men with hepatic impairment Once-daily dosing has not been evaluated in patients with hepatic impairment. Therefore, if prescribing, the physician should carefully assess the individual benefit/risk. (See section 11. <Special populations>.) ● Use in men with diabetes No dose adjustment is required in patients with diabetes.

Child dose

● Use in children and adolescents Persons under 18 years of age: This medicine should not be used.

Precautions

This medication is used for the treatment of erectile dysfunction and benign prostatic hyperplasia, and proper medical assessment must be conducted before use. Sexual activity can impose a burden on the heart, so patients with cardiovascular diseases should only take it after physician’s diagnosis. If an erection lasts longer than 4 hours, it can cause damage to penile tissue, hence immediate medical assistance should be sought in such cases. This drug should not be used by patients who are on nitrate medications due to the risk of excessively low blood pressure. Patients with significant cardiovascular conditions such as myocardial infarction, stroke, or unstable angina should not take this medication. Patients with specific kidney or liver function impairment should use this medication cautiously, and the physician should evaluate the individual risks and benefits. The use of this drug with other erectile dysfunction medications is not recommended, and those with hypersensitivity should avoid it. While taking this medication, sudden vision decrease or hearing loss may occur; in these cases, one should immediately discontinue use and consult a doctor. Caution is advised when taking this medication with alcohol due to potential blood pressure lowering or dizziness. During the treatment with this medication, one should maintain awareness of their condition while driving or operating machinery. In case of overdose, appropriate medical treatment should be sought according to the symptoms, as blood dialysis is not effective for its removal. It should be kept out of reach of children, and maintaining the packaging state is recommended. This medication is metabolized in the liver, thus, patients with impaired liver function may require dose adjustment. Patients must inform their physician of any current medications and health conditions, particularly cardiovascular disease or liver or kidney disorders.

Side effects

Headache, dyspepsia, low back pain, myalgia, congestion, flushing, limb pain, nasopharyngitis, upper respiratory infection, cough, diarrhea, urinary tract infection, gastroesophageal reflux disease, abdominal pain, dizziness, hypertension, priapism, increased blood urea nitrogen, tachycardia, palpitations, conjunctival injection, increased SGPT, chest pressure, vomiting, nausea, increased alkaline phosphatase, fatigue, neck stiffness, urethral pain, kidney pain, dry mouth, heartburn, gastrointestinal disorders, drowsiness, increased white blood cell count, thrombocytopenia, decreased hemoglobin, eye pain, chest pain, arthralgia, hyperventilation, retinal hemorrhage, eyelid swelling, conjunctival hemorrhage, dry eye syndrome, abdominal cramps, increased bilirubin, ejaculation disorder, external genital organ pain, erythema, itching, penile disorder, myocardial infarction, tinnitus, epistaxis, nasal dryness, increased serum creatinine, hiccups, weakness, abdominal discomfort, abdominal pain, allergic reaction, facial edema, fever, increased SGOT, increased hemoglobin, urticaria, Stevens-Johnson syndrome, exfoliative dermatitis, migraine, seizure, transient global amnesia, visual field defect, retinal vein occlusion, retinal artery occlusion, decreased vision, non-arteritic anterior ischemic optic neuropathy, sudden hearing loss, hearing loss, tinnitus, vascular edema, abnormal electrocardiogram, primary sinus bradycardia, chills, musculoskeletal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow film-coated tablets with a rounded triangular shape

Package unit

30 tablets/box [(10 tablets/PTP)*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.